ATRenew (RERE) grants CFO Chen Chen 91,643 stock options
Rhea-AI Filing Summary
ATRenew Inc. (RERE) reported that its Chief Financial Officer, Chen Chen, received multiple option grants on Class A ordinary shares. On 2026-08-18, Chen was granted options to acquire a total of 91,643 shares at an exercise price of $0.10 per share, with exercise dates in 2026–2027 and expirations in 2035–2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Chen Chen
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Options (Right to Buy) | 3,308 | $0.00 | $0.00 |
| Grant/Award | Options (Right to Buy) | 5,572 | $0.00 | $0.00 |
| Grant/Award | Options (Right to Buy) | 64,247 | $0.00 | $0.00 |
| Grant/Award | Options (Right to Buy) | 14,466 | $0.00 | $0.00 |
| Grant/Award | Options (Right to Buy) | 4,050 | $0.00 | $0.00 |
Holdings After Transaction:
Options (Right to Buy) — 91,643 shares (Direct)
Key Figures
Total options granted: 91,643 shares
Exercise price: $0.10 per share
Option tranche 1 size: 3,308 shares
+4 more
7 metrics
Total options granted
91,643 shares
Aggregate options on Class A ordinary shares granted to Chen Chen on 2026-08-18
Exercise price
$0.10 per share
Conversion or exercise price for all reported option grants
Option tranche 1 size
3,308 shares
Options exercisable on 2026-01-01, expiring 2036-01-01
Option tranche 2 size
5,572 shares
Options exercisable on 2026-04-01, expiring 2035-04-01
Largest option tranche
64,247 shares
Options exercisable on 2026-12-15, expiring 2035-12-15
Later-dated tranche
14,466 shares
Options exercisable on 2027-01-01, expiring 2036-01-01
Final tranche
4,050 shares
Options exercisable on 2027-04-01, expiring 2036-04-01
Key Terms
Options (Right to Buy), exercise date, expiration_date, Class A ordinary shares
4 terms
Options (Right to Buy) financial
"security_title: Options (Right to Buy)"
exercise date financial
"exercise_date: 2026-01-01"
expiration_date financial
"expiration_date: 2036-01-01"
FAQ
What did ATRenew Inc. (RERE) disclose about Chen Chen’s recent equity awards?
ATRenew Inc. disclosed that CFO Chen Chen received several option grants on 2026-08-18. These options cover 91,643 Class A ordinary shares at a $0.10 exercise price, with exercise dates in 2026–2027 and expirations between 2035 and 2036.
How many options were granted to ATRenew (RERE) CFO Chen Chen on 2026-08-18?
CFO Chen Chen was granted options over 91,643 Class A ordinary shares on 2026-08-18. The grants consist of several tranches, each with different exercise and expiration dates, all at an exercise price of $0.10 per share.
What is the exercise price of Chen Chen’s new stock options at ATRenew (RERE)?
The new options granted to Chen Chen carry an exercise price of $0.10 per share. Each option relates to ATRenew’s Class A ordinary shares, with various future exercise dates and long-dated expirations in 2035 and 2036.
When can ATRenew (RERE) CFO Chen Chen begin exercising the new options?
The granted options become exercisable on several dates starting in 2026. Specific exercise dates disclosed are 2026-01-01, 2026-04-01, and 2026-12-15, with additional tranches exercisable on 2027-01-01 and 2027-04-01.
What are the expiration dates for Chen Chen’s new ATRenew (RERE) option grants?
The option grants to Chen Chen expire between 2035 and 2036. The filing lists expiration dates of 2035-04-01, 2035-12-15, and 2036-01-01, as well as 2036-04-01, depending on the specific option tranche.
Are Chen Chen’s new ATRenew (RERE) options classified as direct or indirect holdings?
The reported option grants to Chen Chen are classified as direct holdings. Each transaction lists ownership type as direct, indicating the options are held directly rather than through a separate entity or indirect ownership structure.
AI-generated analysis. How Rhea-AI works. Not financial advice.